Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 9, 2026
Gut Microbiome Dysbiosis Promotes Gallstone Formation via Bile Acid Metabolic Disorder: A Multiomics Study
Chongfei Huang, Weijun Xiao, Jinyu Zhao, et al.
Preventive Medicine
|
March 28, 2024
Genetic risk, adherence to healthy lifestyle behaviors, and risk of cholelithiasis: A population-based cohort study
Ningning Mi, Zixin Liang, Man Yang, et al.
Human Cell
|
November 15, 2023
Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1
Mingzhen Bai, Ningzu Jiang, Wenkang Fu, et al.
Frontiers in Pharmacology
|
August 2, 2023
Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
Liang Tian, Chongfei Huang, Wenkang Fu, et al.
Human Cell
|
April 1, 2026
CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations
Jiahui Xi, Mingzhen Bai, Ruyang Zhong, et al.
International Journal of Cancer
|
May 26, 2023
Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts
Qiangsheng He, Chongfei Huang, Xiwen Qin, et al.
Scientific Reports
|
November 29, 2024
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6
Mingzhen Bai, Ruoshui Wang, Chongfei Huang, et al.
Pharmacological Research
|
August 1, 2024
Design of the distribution of iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia
Yawen Lu, Chongfei Huang, WenKang Fu, et al.
BMC Cancer
|
January 4, 2024
Regular use of paracetamol and risk of liver cancer: a prospective cohort study
Liang Tian, Ningning Mi, Leiqing Wang, et al.
Acta Pharmaceutica Sinica. B
|
September 23, 2024
Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing
Wenkang Fu, Yanyan Lin, Mingzhen Bai, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 9, 2026
Gut Microbiome Dysbiosis Promotes Gallstone Formation via Bile Acid Metabolic Disorder: A Multiomics Study
Chongfei Huang, Weijun Xiao, Jinyu Zhao, et al.
Preventive Medicine
|
March 28, 2024
Genetic risk, adherence to healthy lifestyle behaviors, and risk of cholelithiasis: A population-based cohort study
Ningning Mi, Zixin Liang, Man Yang, et al.
Human Cell
|
November 15, 2023
Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1
Mingzhen Bai, Ningzu Jiang, Wenkang Fu, et al.
Frontiers in Pharmacology
|
August 2, 2023
Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
Liang Tian, Chongfei Huang, Wenkang Fu, et al.
Human Cell
|
April 1, 2026
CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations
Jiahui Xi, Mingzhen Bai, Ruyang Zhong, et al.
International Journal of Cancer
|
May 26, 2023
Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts
Qiangsheng He, Chongfei Huang, Xiwen Qin, et al.
Scientific Reports
|
November 29, 2024
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6
Mingzhen Bai, Ruoshui Wang, Chongfei Huang, et al.
Pharmacological Research
|
August 1, 2024
Design of the distribution of iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia
Yawen Lu, Chongfei Huang, WenKang Fu, et al.
BMC Cancer
|
January 4, 2024
Regular use of paracetamol and risk of liver cancer: a prospective cohort study
Liang Tian, Ningning Mi, Leiqing Wang, et al.
Acta Pharmaceutica Sinica. B
|
September 23, 2024
Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing
Wenkang Fu, Yanyan Lin, Mingzhen Bai, et al.
Page
of 3